liver/biliary system
• mice exhibit reduced bile flow, biliary cholesterol secretion, and bile acid secretion compared with wild-type mice
• cangrelor treatment fails to increase of cholesterol, bile acid, and phospholipids biliary secretion unlike in wild-type mice
|
• reduced staining of vesicular structures positive for fluorescent DyLight549 suggests impaired receptor-mediated HDL uptake compared to in similarly treated wild-type cells
• hepatocytes treated with a P2ry13 agonist, cangrelor, fail to exhibit an increase in labeled HDL uptake compared with similarly treated wild-type cells
|
homeostasis/metabolism
• mice exhibit reduced overall macrophage-to-feces reverse cholesterol transport compared with wild-type mice
|
• hepatocytes treated with a P2ry13 agonist, cangrelor, fail to exhibit an increase in labeled HDL uptake compared with similarly treated wild-type cells
• cangrelor treatment fails to increase of cholesterol, bile acid, and phospholipids biliary secretion unlike in wild-type mice
|
cellular
• mice exhibit reduced overall macrophage-to-feces reverse cholesterol transport compared with wild-type mice
|